Global Lipid Nanoparticle (LNP) Formulation Service Market Growth (Status and Outlook) 2025-2031

Product Code: 1394462

Industry: Medical Care

Published: Aug 05,2025

Pages: 139

Delivery Time: 2-3 business days

Global Lipid Nanoparticle (LNP) Formulation Service Market Growth (Status and Outlook) 2025-2031

Product Code: 1394462

Industry: Medical Care

Published: Aug 05,2025

Pages: 139

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Lipid Nanoparticle (LNP) Formulation Service market size will reach US$ 1115 million by 2031.

LNPs (Lipid Nanoparticles) are a novel potential delivery tool in the 100-150 nanometer range, serving as an important alternative to polymer systems. LNPs are lipophilic substances that have been shown to effectively deliver nucleic acid-based therapeutic products. This delivery system utilizes biocompatible lipid materials as carriers, capable of dissolving, encapsulating, adsorbing, and attaching drugs or other bioactive substances. Compared to other delivery systems, LNPs offer numerous advantages, including enhanced drug absorption, modified drug toxicity, improved drug stability, and controlled drug release. As a result, LNPs play an increasingly important role in the delivery of gene therapies, anticancer drugs, proteins, and peptides.

Driven by the expanding pipeline of RNA therapeutics—including mRNA vaccines, siRNA drugs, and gene editing modalities—demand for LNP formulation services has surged across both early discovery and late-stage clinical development. The market is increasingly dominated by integrated CDMO providers with end-to-end capabilities in lipid synthesis, formulation optimization, scale-up, and GMP manufacturing. Leading players such as WuXi STA, Merck, and Evonik are capturing global demand through platform-based offerings and commercial-scale capacity. The sector is witnessing dual consolidation: top-tier CDMOs are gaining share via one-stop service models, while proprietary LNP delivery platforms remain concentrated among a few with ionizable lipid expertise and high encapsulation efficiency. Despite rapid growth, high raw material costs and complex process validation remain key bottlenecks. Future cost compression is expected through modular manufacturing, in-house lipid production, and standardized LNP platforms. Chinese firms are rapidly scaling up their capabilities to serve both domestic nucleic acid innovators and global mRNA vaccine export projects, with select players poised to become competitive globally.

LPI (LP Information)' newest research report, the “Lipid Nanoparticle (LNP) Formulation Service Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticle (LNP) Formulation Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticle (LNP) Formulation Service sales for 2025 through 2031. With Lipid Nanoparticle (LNP) Formulation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticle (LNP) Formulation Service industry.

This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticle (LNP) Formulation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticle (LNP) Formulation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticle (LNP) Formulation Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticle (LNP) Formulation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticle (LNP) Formulation Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticle (LNP) Formulation Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
    mRNA-lipid Nanoparticle
    siRNA-lipid Nanoparticle
    Other

Segmentation by Application:
    Gene Therapy
    Vaccine
    Cancer Treatment

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Cytiva
    Croda International
    Evonik
    Merck KGaA
    Genevant Sciences
    Nippon Fine Chemical
    Polymun Scientific
    Corden Pharma
    Acuitas Therapeutics
    Creative Biolabs
    GenScript
    WuXi STA
    MicroNano Biologics
    Precigenome
    Catalent
    Wacker

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size (2020-2031)
        2.1.2 Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Lipid Nanoparticle (LNP) Formulation Service by Country/Region (2020, 2024 & 2031)
    2.2 Lipid Nanoparticle (LNP) Formulation Service Segment by Type
        2.2.1 mRNA-lipid Nanoparticle
        2.2.2 siRNA-lipid Nanoparticle
        2.2.3 Other
        2.2.4 Lipid Nanoparticle (LNP) Formulation Service Market Size by Type
            2.2.4.1 Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
            2.2.4.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
    2.3 Lipid Nanoparticle (LNP) Formulation Service Segment by Application
        2.3.1 Gene Therapy
        2.3.2 Vaccine
        2.3.3 Cancer Treatment
        2.3.4 Lipid Nanoparticle (LNP) Formulation Service Market Size by Application
            2.3.4.1 Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
            2.3.4.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)

3 Lipid Nanoparticle (LNP) Formulation Service Market Size by Player
    3.1 Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Player
        3.1.1 Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Player (2020-2025)
        3.1.2 Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Player (2020-2025)
    3.2 Global Lipid Nanoparticle (LNP) Formulation Service Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Lipid Nanoparticle (LNP) Formulation Service by Region
    4.1 Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2025)
    4.2 Global Lipid Nanoparticle (LNP) Formulation Service Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Lipid Nanoparticle (LNP) Formulation Service Market Size Growth (2020-2025)
    4.4 APAC Lipid Nanoparticle (LNP) Formulation Service Market Size Growth (2020-2025)
    4.5 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Growth (2020-2025)
    4.6 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2025)
    5.2 Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025)
    5.3 Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2025)
    6.2 APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025)
    6.3 APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2025)
    7.2 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025)
    7.3 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service by Region (2020-2025)
    8.2 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025)
    8.3 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Lipid Nanoparticle (LNP) Formulation Service Market Forecast
    10.1 Global Lipid Nanoparticle (LNP) Formulation Service Forecast by Region (2026-2031)
        10.1.1 Global Lipid Nanoparticle (LNP) Formulation Service Forecast by Region (2026-2031)
        10.1.2 Americas Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.1.3 APAC Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.1.4 Europe Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.1.5 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Forecast
    10.2 Americas Lipid Nanoparticle (LNP) Formulation Service Forecast by Country (2026-2031)
        10.2.1 United States Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.2.2 Canada Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.2.3 Mexico Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.2.4 Brazil Market Lipid Nanoparticle (LNP) Formulation Service Forecast
    10.3 APAC Lipid Nanoparticle (LNP) Formulation Service Forecast by Region (2026-2031)
        10.3.1 China Lipid Nanoparticle (LNP) Formulation Service Market Forecast
        10.3.2 Japan Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.3.3 Korea Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.3.4 Southeast Asia Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.3.5 India Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.3.6 Australia Market Lipid Nanoparticle (LNP) Formulation Service Forecast
    10.4 Europe Lipid Nanoparticle (LNP) Formulation Service Forecast by Country (2026-2031)
        10.4.1 Germany Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.4.2 France Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.4.3 UK Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.4.4 Italy Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.4.5 Russia Market Lipid Nanoparticle (LNP) Formulation Service Forecast
    10.5 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Forecast by Region (2026-2031)
        10.5.1 Egypt Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.5.2 South Africa Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.5.3 Israel Market Lipid Nanoparticle (LNP) Formulation Service Forecast
        10.5.4 Turkey Market Lipid Nanoparticle (LNP) Formulation Service Forecast
    10.6 Global Lipid Nanoparticle (LNP) Formulation Service Forecast by Type (2026-2031)
    10.7 Global Lipid Nanoparticle (LNP) Formulation Service Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Lipid Nanoparticle (LNP) Formulation Service Forecast

11 Key Players Analysis
    11.1 Cytiva
        11.1.1 Cytiva Company Information
        11.1.2 Cytiva Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.1.3 Cytiva Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Cytiva Main Business Overview
        11.1.5 Cytiva Latest Developments
    11.2 Croda International
        11.2.1 Croda International Company Information
        11.2.2 Croda International Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.2.3 Croda International Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Croda International Main Business Overview
        11.2.5 Croda International Latest Developments
    11.3 Evonik
        11.3.1 Evonik Company Information
        11.3.2 Evonik Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.3.3 Evonik Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 Evonik Main Business Overview
        11.3.5 Evonik Latest Developments
    11.4 Merck KGaA
        11.4.1 Merck KGaA Company Information
        11.4.2 Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.4.3 Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Merck KGaA Main Business Overview
        11.4.5 Merck KGaA Latest Developments
    11.5 Genevant Sciences
        11.5.1 Genevant Sciences Company Information
        11.5.2 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.5.3 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Genevant Sciences Main Business Overview
        11.5.5 Genevant Sciences Latest Developments
    11.6 Nippon Fine Chemical
        11.6.1 Nippon Fine Chemical Company Information
        11.6.2 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.6.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Nippon Fine Chemical Main Business Overview
        11.6.5 Nippon Fine Chemical Latest Developments
    11.7 Polymun Scientific
        11.7.1 Polymun Scientific Company Information
        11.7.2 Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.7.3 Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 Polymun Scientific Main Business Overview
        11.7.5 Polymun Scientific Latest Developments
    11.8 Corden Pharma
        11.8.1 Corden Pharma Company Information
        11.8.2 Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.8.3 Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Corden Pharma Main Business Overview
        11.8.5 Corden Pharma Latest Developments
    11.9 Acuitas Therapeutics
        11.9.1 Acuitas Therapeutics Company Information
        11.9.2 Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.9.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Acuitas Therapeutics Main Business Overview
        11.9.5 Acuitas Therapeutics Latest Developments
    11.10 Creative Biolabs
        11.10.1 Creative Biolabs Company Information
        11.10.2 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.10.3 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Creative Biolabs Main Business Overview
        11.10.5 Creative Biolabs Latest Developments
    11.11 GenScript
        11.11.1 GenScript Company Information
        11.11.2 GenScript Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.11.3 GenScript Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 GenScript Main Business Overview
        11.11.5 GenScript Latest Developments
    11.12 WuXi STA
        11.12.1 WuXi STA Company Information
        11.12.2 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.12.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 WuXi STA Main Business Overview
        11.12.5 WuXi STA Latest Developments
    11.13 MicroNano Biologics
        11.13.1 MicroNano Biologics Company Information
        11.13.2 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.13.3 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 MicroNano Biologics Main Business Overview
        11.13.5 MicroNano Biologics Latest Developments
    11.14 Precigenome
        11.14.1 Precigenome Company Information
        11.14.2 Precigenome Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.14.3 Precigenome Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Precigenome Main Business Overview
        11.14.5 Precigenome Latest Developments
    11.15 Catalent
        11.15.1 Catalent Company Information
        11.15.2 Catalent Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.15.3 Catalent Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 Catalent Main Business Overview
        11.15.5 Catalent Latest Developments
    11.16 Wacker
        11.16.1 Wacker Company Information
        11.16.2 Wacker Lipid Nanoparticle (LNP) Formulation Service Product Offered
        11.16.3 Wacker Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Wacker Main Business Overview
        11.16.5 Wacker Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Lipid Nanoparticle (LNP) Formulation Service Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of mRNA-lipid Nanoparticle
 Table 4. Major Players of siRNA-lipid Nanoparticle
 Table 5. Major Players of Other
 Table 6. Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 7. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025) & ($ millions)
 Table 8. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
 Table 9. Lipid Nanoparticle (LNP) Formulation Service Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 10. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025) & ($ millions)
 Table 11. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)
 Table 12. Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Player (2020-2025) & ($ millions)
 Table 13. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Player (2020-2025)
 Table 14. Lipid Nanoparticle (LNP) Formulation Service Key Players Head office and Products Offered
 Table 15. Lipid Nanoparticle (LNP) Formulation Service Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 16. New Products and Potential Entrants
 Table 17. Mergers & Acquisitions, Expansion
 Table 18. Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2025) & ($ millions)
 Table 19. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Region (2020-2025)
 Table 20. Global Lipid Nanoparticle (LNP) Formulation Service Revenue by Country/Region (2020-2025) & ($ millions)
 Table 21. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Country/Region (2020-2025)
 Table 22. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2025) & ($ millions)
 Table 23. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Country (2020-2025)
 Table 24. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025) & ($ millions)
 Table 25. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
 Table 26. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025) & ($ millions)
 Table 27. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)
 Table 28. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2025) & ($ millions)
 Table 29. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Region (2020-2025)
 Table 30. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025) & ($ millions)
 Table 31. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025) & ($ millions)
 Table 32. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country (2020-2025) & ($ millions)
 Table 33. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Country (2020-2025)
 Table 34. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025) & ($ millions)
 Table 35. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Region (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Type (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2020-2025) & ($ millions)
 Table 39. Key Market Drivers & Growth Opportunities of Lipid Nanoparticle (LNP) Formulation Service
 Table 40. Key Market Challenges & Risks of Lipid Nanoparticle (LNP) Formulation Service
 Table 41. Key Industry Trends of Lipid Nanoparticle (LNP) Formulation Service
 Table 42. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 43. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share Forecast by Region (2026-2031)
 Table 44. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 45. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 46. Cytiva Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 47. Cytiva Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 48. Cytiva Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 49. Cytiva Main Business
 Table 50. Cytiva Latest Developments
 Table 51. Croda International Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 52. Croda International Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 53. Croda International Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 54. Croda International Main Business
 Table 55. Croda International Latest Developments
 Table 56. Evonik Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 57. Evonik Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 58. Evonik Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 59. Evonik Main Business
 Table 60. Evonik Latest Developments
 Table 61. Merck KGaA Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 62. Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 63. Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 64. Merck KGaA Main Business
 Table 65. Merck KGaA Latest Developments
 Table 66. Genevant Sciences Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 67. Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 68. Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 69. Genevant Sciences Main Business
 Table 70. Genevant Sciences Latest Developments
 Table 71. Nippon Fine Chemical Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 72. Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 73. Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 74. Nippon Fine Chemical Main Business
 Table 75. Nippon Fine Chemical Latest Developments
 Table 76. Polymun Scientific Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 77. Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 78. Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 79. Polymun Scientific Main Business
 Table 80. Polymun Scientific Latest Developments
 Table 81. Corden Pharma Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 82. Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 83. Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 84. Corden Pharma Main Business
 Table 85. Corden Pharma Latest Developments
 Table 86. Acuitas Therapeutics Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 87. Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 88. Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 89. Acuitas Therapeutics Main Business
 Table 90. Acuitas Therapeutics Latest Developments
 Table 91. Creative Biolabs Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 92. Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 93. Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 94. Creative Biolabs Main Business
 Table 95. Creative Biolabs Latest Developments
 Table 96. GenScript Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 97. GenScript Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 98. GenScript Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 99. GenScript Main Business
 Table 100. GenScript Latest Developments
 Table 101. WuXi STA Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 102. WuXi STA Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 103. WuXi STA Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 104. WuXi STA Main Business
 Table 105. WuXi STA Latest Developments
 Table 106. MicroNano Biologics Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 107. MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 108. MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 109. MicroNano Biologics Main Business
 Table 110. MicroNano Biologics Latest Developments
 Table 111. Precigenome Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 112. Precigenome Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 113. Precigenome Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 114. Precigenome Main Business
 Table 115. Precigenome Latest Developments
 Table 116. Catalent Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 117. Catalent Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 118. Catalent Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 119. Catalent Main Business
 Table 120. Catalent Latest Developments
 Table 121. Wacker Details, Company Type, Lipid Nanoparticle (LNP) Formulation Service Area Served and Its Competitors
 Table 122. Wacker Lipid Nanoparticle (LNP) Formulation Service Product Offered
 Table 123. Wacker Lipid Nanoparticle (LNP) Formulation Service Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 124. Wacker Main Business
 Table 125. Wacker Latest Developments


List of Figures
 Figure 1. Lipid Nanoparticle (LNP) Formulation Service Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Lipid Nanoparticle (LNP) Formulation Service Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Lipid Nanoparticle (LNP) Formulation Service Sales Market Share by Country/Region (2024)
 Figure 8. Lipid Nanoparticle (LNP) Formulation Service Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type in 2024
 Figure 10. Lipid Nanoparticle (LNP) Formulation Service in Gene Therapy
 Figure 11. Global Lipid Nanoparticle (LNP) Formulation Service Market: Gene Therapy (2020-2025) & ($ millions)
 Figure 12. Lipid Nanoparticle (LNP) Formulation Service in Vaccine
 Figure 13. Global Lipid Nanoparticle (LNP) Formulation Service Market: Vaccine (2020-2025) & ($ millions)
 Figure 14. Lipid Nanoparticle (LNP) Formulation Service in Cancer Treatment
 Figure 15. Global Lipid Nanoparticle (LNP) Formulation Service Market: Cancer Treatment (2020-2025) & ($ millions)
 Figure 16. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application in 2024
 Figure 17. Global Lipid Nanoparticle (LNP) Formulation Service Revenue Market Share by Player in 2024
 Figure 18. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size 2020-2025 ($ millions)
 Figure 20. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size 2020-2025 ($ millions)
 Figure 21. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size 2020-2025 ($ millions)
 Figure 23. Americas Lipid Nanoparticle (LNP) Formulation Service Value Market Share by Country in 2024
 Figure 24. United States Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Region in 2024
 Figure 29. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)
 Figure 31. China Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Country in 2024
 Figure 38. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Lipid Nanoparticle (LNP) Formulation Service Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 54. APAC Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 55. Europe Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 57. United States Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 58. Canada Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 61. China Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 62. Japan Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 63. Korea Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 65. India Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 66. Australia Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 67. Germany Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 68. France Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 69. UK Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 70. Italy Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 71. Russia Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 74. Israel Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)
 Figure 76. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Lipid Nanoparticle (LNP) Formulation Service Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Lipid Nanoparticle (LNP) Formulation Service Market Size 2026-2031 ($ millions)

Companies Mentioned

Cytiva

Croda International

Evonik

Merck KGaA

Genevant Sciences

Nippon Fine Chemical

Polymun Scientific

Corden Pharma

Acuitas Therapeutics

Creative Biolabs

GenScript

WuXi STA

MicroNano Biologics

Precigenome

Catalent

Wacker

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff